Literature DB >> 6196907

Monoclonal antibodies to the HN glycoprotein of Newcastle disease virus. Biological characterization and use for strain comparisons.

K Nishikawa, S Isomura, S Suzuki, E Watanabe, M Hamaguchi, T Yoshida, Y Nagai.   

Abstract

We have isolated nine hybridomas secreting monoclonal antibodies directed against the HN glycoprotein of D26 strain of Newcastle disease virus (NDV) and classified them into three groups by their biological reactivities. The group I antibodies from six clones had high hemagglutination inhibition (HI) and neutralization titers, and exhibited neuraminidase inhibition (NI) activity with substrates, both bovine fetuin and N-acetyl neuraminlactose, although the levels of maximum inhibition were greater with the former substrate. The group II antibodies from two clones also had high HI activity but showed a strongly substrate-dependent NI, with efficient inhibition against fetuin and a total lack of inhibition against neuraminlactose. These antibodies had neutralization capacity but the titers were much lower than those of group I antibodies. One clone (group III) secreted antibody which exhibited HI and NI with either substrate but no detectable neutralization activity. Frequency of isolation of antigenic variants and competitive binding assays have shown that group I and group II antibodies may recognize distinct regions not overlapping each other whereas antibodies placed within each of the two groups are to the respective same overlapping regions. The site of group III seemed to be close to or overlap the group I determinant but distinct from group II region. Using the isolated monoclonal antibodies we compared seven heterologous strains by HI and neutralization tests as well as by enzyme-linked immunosorbent assay. The results indicated that the regions recognized by group I antibodies would be conserved among the strains whereas those by the other two antibody groups might undergo considerable changes.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6196907     DOI: 10.1016/0042-6822(83)90086-7

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  23 in total

1.  Selection of unique antigenic variants of Newcastle disease virus with neutralizing monoclonal antibodies and anti-immunoglobulin.

Authors:  R M Iorio; M A Bratt
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

2.  Topological and operational delineation of antigenic sites on the HN glycoprotein of Newcastle disease virus and their structural requirements.

Authors:  K Nishikawa; T Morishima; T Toyoda; T Miyadai; T Yokochi; T Yoshida; Y Nagai
Journal:  J Virol       Date:  1986-12       Impact factor: 5.103

3.  Evaluation of the use of monoclonal antibodies to hemagglutinin and fusion glycoproteins of Newcastle disease virus for virus identification and strain differentiation purposes.

Authors:  G Meulemans; M Gonze; M C Carlier; P Petit; A Burny
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

4.  Antigenic relationships between avian paramyxoviruses. I. Quantitative characteristics based on hemagglutination and neuraminidase inhibition tests.

Authors:  M Lipkind; E Shihmanter
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

5.  Neutralizing activity of the antibodies against two kinds of envelope glycoproteins of Sendai virus.

Authors:  H Tozawa; H Komatsu; K Ohkata; T Nakajima; M Watanabe; Y Tanaka; M Arifuku
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

6.  Isolation of a biologically active soluble form of the hemagglutinin-neuraminidase protein of Sendai virus.

Authors:  S D Thompson; W G Laver; K G Murti; A Portner
Journal:  J Virol       Date:  1988-12       Impact factor: 5.103

7.  Antigenic mapping and functional analysis of the F protein of Newcastle disease virus using monoclonal antibodies.

Authors:  G Abenes; H Kida; R Yanagawa
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

8.  Newcastle disease vaccine (La Sota) strain specific monoclonal antibody. Brief report.

Authors:  J Erdei; J Erdei; K Bachir; E F Kaleta; K F Shortridge; B Lomniczi
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

9.  Characterization of French avian paramyxovirus type 1 (PMV 1) isolates with a Panel of monoclonal antibodies to the Ploufragan strain of Newcastle disease virus.

Authors:  V Jestin; M Cherbonnel; M Morin; M Guittet; G Bennejean
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

10.  F0-containing noninfectious Sendai virus can initiate replication in mouse lungs but requires a relatively long incubation period.

Authors:  K Kiyotani; T Sakaguchi; Y Fujii; T Yoshida
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.